Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis.

Autor: Deipolyi AR; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Johnson CB; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Riedl CC; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Kunin H; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Solomon SB; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Oklu R; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Hsu M; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Moskowitz CS; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Kombak FE; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Bhanot U; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.)., Erinjeri JP; From the Department of Surgery, West Virginia University/Charleston Division, Charleston Area Medical Center, 3200 MacCorkle Ave SE, Charleston, WV 25304 (A.R.D.); Department of Radiation Oncology, Inova Schar Cancer Institute, Fairfax, Va (C.B.J.); imagingwest, Hawthorne, NY (C.C.R.); Interventional Radiology Service (H.K., S.B.S., J.P.E.), Department of Epidemiology and Biostatistics (M.H., C.S.M.), and Department of Pathology, Precision Pathology Center (F.E.K., U.B.), Memorial Sloan-Kettering Cancer Center, New York, NY; and Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, Scottsdale, Ariz (R.O.).

Publikováno v: Radiology [Radiology] 2023 Jan; Vol. 306 (1), pp. 279-287. Date of Electronic Publication: 2022 Aug 16.

Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer.

Autor: Ciampricotti M; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Karakousi T; Department of Pathology, New York University School of Medicine, New York, New York., Richards AL; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Quintanal-Villalonga À; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Karatza A; Perlmutter Cancer Center, New York University Langone Health, New York, New York., Caeser R; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Costa EA; Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York., Allaj V; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Manoj P; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Spainhower KB; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Kombak FE; Precision Pathology Center, Memorial Sloan Kettering Cancer Center, New York, New York., Sanchez-Rivera FJ; Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Jaspers JE; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Zavitsanou AM; Department of Pathology, New York University School of Medicine, New York, New York., Maddalo D; Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Ventura A; Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Rideout WM; David H. Koch Institute for Integrative Cancer Research, Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts., Akama-Garren EH; David H. Koch Institute for Integrative Cancer Research, Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts., Jacks T; David H. Koch Institute for Integrative Cancer Research, Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts., Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Sen T; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Oliver TG; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Poirier JT; Perlmutter Cancer Center, New York University Langone Health, New York, New York., Papagiannakopoulos T; Department of Pathology, New York University School of Medicine, New York, New York.; Perlmutter Cancer Center, New York University Langone Health, New York, New York., Rudin CM; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: Cancer discovery [Cancer Discov] 2021 Dec 01; Vol. 11 (12), pp. 3214-3229.

Quantitative Assessment of Liver Fibrosis by Digital Image Analysis: Relationship to Ishak Staging and Elasticity by Shear-wave Elastography

Autor: Yegin, EG, Yegin, K, Kombak, FE, Karatay, E, Tuney, D, Celikel, CA, Ozdogan, OC

… Amer Assoc Study Liver Dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10007::3e254519cf7fa0f281d8328f29f353d5
https://hdl.handle.net/20.500.11831/6493

BRAFV600E Immunohistochemistry in Papillary Thyroid Carcinomas: Relationship Between Clinical and Morphological Parameters.

Autor: Kombak FE; Department of Pathology, Marmara University, School of Medicine, İSTANBUL, TURKEY., Özkan N, Uğurlu MÜ, Kaya H

Publikováno v: Turk patoloji dergisi [Turk Patoloji Derg] 2019; Vol. 35 (2), pp. 83-91.

Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer

Autor: Kombak FE, Şahin H, Mollamemişoğlu H, Önem İ, Kaya H, Buğdaycı O, Arıbal E

Publikováno v: Turkish journal of medical sciences [Turk J Med Sci] 2017 Dec 19; Vol. 47 (6), pp. 1791-1796. Date of Electronic Publication: 2017 Dec 19.